Focused on transformative treatment technologies in dermatology and oncology.
The Company's current focus is a range of dermatological applications utilising its unique formulation and delivery technologies to meet currently unmet needs in the skincare market.
Half-yearly results for the six months ended 30 September 2023
Watch the Life Sciences Investor Forum
CEO Interview re Commercial Skincare